Workflow
Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating
SanofiSanofi(US:SNY) Yahoo Finance·2025-10-02 08:15

With significant upside potential, Sanofi (NASDAQ:SNY) secures a spot on our list of the 12 Best Widow and Orphan Stocks to Buy According to Analysts. Sanofi (SNY) Caps Cost of Any Insulin Product at 35perMonth;BerenbergReaffirmsItsBuyRatingOnSeptember29,BerenbergreaffirmeditsBuyratingonSanofi(NASDAQ:SNY)withapricetargetofEUR110.00,citingbetterreturnsfromthecompany’smedicationpipeline.Analysts’estimatesforthe35 per Month; Berenberg Reaffirms Its Buy Rating On September 29, Berenberg reaffirmed its Buy rating on Sanofi (NASDAQ:SNY) with a price target of EUR110.00, citing better returns from the company’s medication pipeline. Analysts’ estimates for the 111.7 billion market-cap pharmaceutical company range betw ...